Most Popular Brands: Fioricet, Dolgic Plus
This is a combination product of butalbital, acetaminophen, and caffeine used to for relief of the symptomatic complex of tension or muscle contraction headache. Brand names include Anolor 300; Dolgic® LQ; Dolgic® Plus; Esgic-Plus™; Esgic®; Fioricet®; Medigesic®; Repan®; Zebutal™
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Migraine | 33 |
|
|
|
7 | ||
| Headaches | 16 |
|
|
2 | |||
| Migraine Headaches | 13 |
|
2 | ||||
| Pain | 6 |
|
1 | ||||
| Other | 5 | 0 | |||||
| Constant headache | 5 | 0 |
See all 59 patients currently taking Butalbital, Acetaminophen, and Caffeine
Mouse over the table for more information
Top 10 dosages based on patients currently taking Butalbital, Acetaminophen, and Caffeine. See all 23 dosages ►
| 10mg as needed | 1 as needed | 20mg as needed | 2 325mg-50mg-40mg as needed | 2 as needed | 325 mg-50 mg-40 mg as needed | 325mg-50mg-40mg as needed | 3 325mg-50mg-40mg as needed | 4 325mg-50mg-40mg as needed | 500mg-50mg-40mg as needed | 500mg as needed | 50mg as needed | 750mg-50mg-40mg as needed | as needed | daily | 4 mg daily | 50 mg daily | 325 mg-50 mg-40 mg/15 mL daily | 325 mg-50 mg-40 mg daily | 415 mg daily | 2 x 325 mg-50 mg-40 mg daily | 3 x 325 mg-50 mg-40 mg daily | 6 x 325 mg-50 mg-40 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
5
|
1
|
1
|
20
|
1
|
1
|
2
|
2
|
3
|
1
|
3
|
1
|
1
|
1
|
1
|
3
|
1
|
2
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
7 | 37% |
|
|
Did not seem to work
|
6 | 32% |
|
|
Other
|
6 | 32% |
|
|
Course of treatment ended
|
3 | 16% |
|
|
Expense
|
1 | 5% |
|
|
Side effects too severe
|
1 | 5% |
|
See all 19 patients who’ve stopped taking Butalbital, Acetaminophen, and Caffeine
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.